RVL Pharmaceuticals Market Cap

RVL Pharmaceuticals has a market cap or net worth of $111.00 as of April 24, 2024. Its market cap has decreased by -100.00% in one year.

Market Cap

111.00

Enterprise Value

38.99M

1-Year Change

-100.00%

Ranking

n/a

Market Cap Chart

Since October 18, 2018, RVL Pharmaceuticals's market cap has decreased from $416.90M to $111.00, a decrease of -100.00%. That is a compound annual growth rate of -95.13%.

Market Cap History

Date	Market Cap	% Change
Oct 20, 2023	2.80M	-33.33%
Oct 19, 2023	4.20M	-28.81%
Oct 18, 2023	5.90M	15.69%
Oct 17, 2023	5.10M	-12.07%
Oct 16, 2023	5.80M	-20.55%
Oct 13, 2023	7.30M	17.74%
Oct 12, 2023	6.20M	-60.26%
Oct 11, 2023	15.60M	-
Oct 10, 2023	15.60M	-17.89%
Oct 9, 2023	19.00M	52.00%
Oct 6, 2023	12.50M	14.68%
Oct 5, 2023	10.90M	-5.22%
Oct 4, 2023	11.50M	-9.45%
Oct 3, 2023	12.70M	-
Oct 2, 2023	12.70M	45.98%
Sep 29, 2023	8.70M	11.54%
Sep 28, 2023	7.80M	-2.50%
Sep 27, 2023	8.00M	-5.88%
Sep 26, 2023	8.50M	-3.41%
Sep 25, 2023	8.80M	-12.00%
Sep 22, 2023	10.00M	-5.66%
Sep 21, 2023	10.60M	-8.62%
Sep 20, 2023	11.60M	0.87%
Sep 19, 2023	11.50M	-4.17%
Sep 18, 2023	12.00M	-0.83%

View and export this data all the way back to 2018. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	695.32B
Novo Nordisk	564.00B
UnitedHealth Group	452.88B
Johnson & Johnson	359.35B
Merck & Co.	321.49B
AbbVie	297.27B
AstraZeneca	217.39B
Thermo Fisher	209.32B

Market Cap Rankings